In a study, researchers aimed to evaluate how age and sex influence the efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dipeptidyl peptidase...
Tina Copple,
DNP, APRN, FNP-BC, ADM-BC, CDCES
Family Nurse Practitioner, Diabetes and Glandular Disease Clinic
Empagliflozin Lowers Cardiovascular Death and Mortality in High-Risk Patients With Type 2 Diabetes
Researchers of a large, randomized trial evaluated the cardiovascular effects of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, in patients...